![Xuedong Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Xuedong Liu is the founder and the Scientific Advisor at OnKure, Inc., a company founded in 2011.
He is currently the Director at Vesicle Therapeutics, Inc.
Posizioni attive di Xuedong Liu
Società | Posizione | Inizio |
---|---|---|
OnKure, Inc.
![]() OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Fondatore | 01/04/2011 |
Vesicle Therapeutics, Inc.
![]() Vesicle Therapeutics, Inc. BiotechnologyHealth Technology Vesicle Therapeutics, Inc. is a biotechnology company that operates in the field of life sciences. The company is based in Niwot, CO. The CEO of the company is Donna Peak. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
OnKure, Inc.
![]() OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Health Technology |
Vesicle Therapeutics, Inc.
![]() Vesicle Therapeutics, Inc. BiotechnologyHealth Technology Vesicle Therapeutics, Inc. is a biotechnology company that operates in the field of life sciences. The company is based in Niwot, CO. The CEO of the company is Donna Peak. | Health Technology |
- Borsa valori
- Insiders
- Xuedong Liu